titanium dioxide has been researched along with Parkinson Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Buzoianu, AD; Castellani, RJ; Feng, L; Lafuente, JV; Muresanu, DF; Niu, F; Nozari, A; Patnaik, R; Sahib, S; Sharma, A; Sharma, HS; Tian, ZR; Wang, Z; Wiklund, L | 1 |
Buzoianu, AD; Castellani, RJ; Lafuente, JV; Muresanu, DF; Nozari, A; Patnaik, R; Sahib, S; Sharma, A; Sharma, HS; Tian, ZR; Wiklund, L | 1 |
Coffman, SS; Heller, A | 1 |
1 review(s) available for titanium dioxide and Parkinson Disease
Article | Year |
---|---|
Mild traumatic brain injury exacerbates Parkinson's disease induced hemeoxygenase-2 expression and brain pathology: Neuroprotective effects of co-administration of TiO
Topics: Amino Acids; Brain; Brain Concussion; Humans; Mesenchymal Stem Cells; Neuroprotective Agents; Parkinson Disease; Titanium | 2020 |
2 other study(ies) available for titanium dioxide and Parkinson Disease
Article | Year |
---|---|
Co-administration of TiO
Topics: Benzofurans; Brain Injuries, Traumatic; Humans; Mesenchymal Stem Cells; Neuroprotection; Parkinson Disease; Titanium | 2020 |
Crystals in the Substantia Nigra.
Topics: Aged; Calcium Compounds; Calcium Oxalate; Ferric Compounds; Humans; Oxides; Parkinson Disease; Substantia Nigra; Titanium | 2019 |